Low central nervous system penetration of N2,N4,N6,-trihydroxymethyl-N2,N4,N6,-trimethylmelamine (Trimelamol): a cytotoxic s-triazine with reduced neurotoxicity.

Trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine) is an analogue of pentamethylmelamine (PMM). In early clinical trials PMM failed to show significant anti-tumour activity in man which was attributed to poor metabolic activation. Trimelamol does not require activation and is therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Judson, I. R., Rutty, C. J., Abel, G., Graham, M. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1986
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001385/
https://www.ncbi.nlm.nih.gov/pubmed/3087399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001385/
https://www.ncbi.nlm.nih.gov/pubmed/3087399

Ejemplares similares